nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—CYP2C9—Capecitabine—colon cancer	0.21	0.628	CbGbCtD
Tolcapone—CYP2C9—Fluorouracil—colon cancer	0.125	0.372	CbGbCtD
Tolcapone—Tolmetin—PTGS2—colon cancer	0.00201	1	CrCbGaD
Tolcapone—Anaemia—Fluorouracil—colon cancer	0.00113	0.00171	CcSEcCtD
Tolcapone—Loss of consciousness—Irinotecan—colon cancer	0.00113	0.0017	CcSEcCtD
Tolcapone—Myalgia—Vincristine—colon cancer	0.00112	0.00169	CcSEcCtD
Tolcapone—Cough—Irinotecan—colon cancer	0.00112	0.00169	CcSEcCtD
Tolcapone—Weight decreased—Capecitabine—colon cancer	0.00111	0.00168	CcSEcCtD
Tolcapone—Hypertension—Irinotecan—colon cancer	0.00111	0.00167	CcSEcCtD
Tolcapone—Pneumonia—Capecitabine—colon cancer	0.0011	0.00166	CcSEcCtD
Tolcapone—Infestation NOS—Capecitabine—colon cancer	0.0011	0.00165	CcSEcCtD
Tolcapone—Infestation—Capecitabine—colon cancer	0.0011	0.00165	CcSEcCtD
Tolcapone—Acute coronary syndrome—Capecitabine—colon cancer	0.00108	0.00163	CcSEcCtD
Tolcapone—Lethargy—Methotrexate—colon cancer	0.00108	0.00163	CcSEcCtD
Tolcapone—Cerebrovascular accident—Methotrexate—colon cancer	0.00108	0.00163	CcSEcCtD
Tolcapone—Discomfort—Irinotecan—colon cancer	0.00108	0.00162	CcSEcCtD
Tolcapone—Myocardial infarction—Capecitabine—colon cancer	0.00108	0.00162	CcSEcCtD
Tolcapone—Neuropathy peripheral—Capecitabine—colon cancer	0.00108	0.00162	CcSEcCtD
Tolcapone—Oedema—Vincristine—colon cancer	0.00107	0.00162	CcSEcCtD
Tolcapone—Stomatitis—Capecitabine—colon cancer	0.00107	0.00161	CcSEcCtD
Tolcapone—Infection—Vincristine—colon cancer	0.00107	0.00161	CcSEcCtD
Tolcapone—Urinary tract infection—Capecitabine—colon cancer	0.00107	0.00161	CcSEcCtD
Tolcapone—Osteoarthritis—Methotrexate—colon cancer	0.00106	0.0016	CcSEcCtD
Tolcapone—Confusional state—Irinotecan—colon cancer	0.00105	0.00159	CcSEcCtD
Tolcapone—Nervous system disorder—Vincristine—colon cancer	0.00105	0.00159	CcSEcCtD
Tolcapone—Thrombocytopenia—Vincristine—colon cancer	0.00105	0.00158	CcSEcCtD
Tolcapone—Haematuria—Capecitabine—colon cancer	0.00105	0.00158	CcSEcCtD
Tolcapone—Oedema—Irinotecan—colon cancer	0.00105	0.00158	CcSEcCtD
Tolcapone—Chest pain—Fluorouracil—colon cancer	0.00105	0.00158	CcSEcCtD
Tolcapone—Myalgia—Fluorouracil—colon cancer	0.00105	0.00158	CcSEcCtD
Tolcapone—Infection—Irinotecan—colon cancer	0.00104	0.00157	CcSEcCtD
Tolcapone—Hyperhidrosis—Vincristine—colon cancer	0.00104	0.00156	CcSEcCtD
Tolcapone—Epistaxis—Capecitabine—colon cancer	0.00104	0.00156	CcSEcCtD
Tolcapone—Discomfort—Fluorouracil—colon cancer	0.00103	0.00156	CcSEcCtD
Tolcapone—Shock—Irinotecan—colon cancer	0.00103	0.00155	CcSEcCtD
Tolcapone—Nervous system disorder—Irinotecan—colon cancer	0.00103	0.00155	CcSEcCtD
Tolcapone—Thrombocytopenia—Irinotecan—colon cancer	0.00102	0.00154	CcSEcCtD
Tolcapone—Anorexia—Vincristine—colon cancer	0.00102	0.00154	CcSEcCtD
Tolcapone—Irritability—Methotrexate—colon cancer	0.00101	0.00153	CcSEcCtD
Tolcapone—Hyperhidrosis—Irinotecan—colon cancer	0.00101	0.00152	CcSEcCtD
Tolcapone—Confusional state—Fluorouracil—colon cancer	0.00101	0.00152	CcSEcCtD
Tolcapone—Mood swings—Methotrexate—colon cancer	0.001	0.00151	CcSEcCtD
Tolcapone—Hypotension—Vincristine—colon cancer	0.001	0.00151	CcSEcCtD
Tolcapone—Bradycardia—Capecitabine—colon cancer	0.001	0.00151	CcSEcCtD
Tolcapone—Oedema—Fluorouracil—colon cancer	0.001	0.00151	CcSEcCtD
Tolcapone—Anorexia—Irinotecan—colon cancer	0.000997	0.0015	CcSEcCtD
Tolcapone—Infection—Fluorouracil—colon cancer	0.000995	0.0015	CcSEcCtD
Tolcapone—Haemoglobin—Capecitabine—colon cancer	0.00099	0.00149	CcSEcCtD
Tolcapone—Rhinitis—Capecitabine—colon cancer	0.000988	0.00149	CcSEcCtD
Tolcapone—Haemorrhage—Capecitabine—colon cancer	0.000985	0.00149	CcSEcCtD
Tolcapone—Nervous system disorder—Fluorouracil—colon cancer	0.000982	0.00148	CcSEcCtD
Tolcapone—Thrombocytopenia—Fluorouracil—colon cancer	0.000981	0.00148	CcSEcCtD
Tolcapone—Hypoaesthesia—Capecitabine—colon cancer	0.00098	0.00148	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000979	0.00147	CcSEcCtD
Tolcapone—Pharyngitis—Capecitabine—colon cancer	0.000978	0.00147	CcSEcCtD
Tolcapone—Tachycardia—Fluorouracil—colon cancer	0.000978	0.00147	CcSEcCtD
Tolcapone—Hypotension—Irinotecan—colon cancer	0.000977	0.00147	CcSEcCtD
Tolcapone—Urinary tract disorder—Capecitabine—colon cancer	0.000973	0.00147	CcSEcCtD
Tolcapone—Oedema peripheral—Capecitabine—colon cancer	0.000971	0.00146	CcSEcCtD
Tolcapone—Urethral disorder—Capecitabine—colon cancer	0.000966	0.00146	CcSEcCtD
Tolcapone—Paraesthesia—Vincristine—colon cancer	0.000964	0.00145	CcSEcCtD
Tolcapone—Anorexia—Fluorouracil—colon cancer	0.000955	0.00144	CcSEcCtD
Tolcapone—Paraesthesia—Irinotecan—colon cancer	0.000939	0.00142	CcSEcCtD
Tolcapone—Hypotension—Fluorouracil—colon cancer	0.000936	0.00141	CcSEcCtD
Tolcapone—Decreased appetite—Vincristine—colon cancer	0.000934	0.00141	CcSEcCtD
Tolcapone—Dyspnoea—Irinotecan—colon cancer	0.000933	0.00141	CcSEcCtD
Tolcapone—Erythema multiforme—Capecitabine—colon cancer	0.000932	0.0014	CcSEcCtD
Tolcapone—Somnolence—Irinotecan—colon cancer	0.00093	0.0014	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Vincristine—colon cancer	0.000927	0.0014	CcSEcCtD
Tolcapone—Fatigue—Vincristine—colon cancer	0.000926	0.0014	CcSEcCtD
Tolcapone—Dyspepsia—Irinotecan—colon cancer	0.000921	0.00139	CcSEcCtD
Tolcapone—Tinnitus—Capecitabine—colon cancer	0.000919	0.00138	CcSEcCtD
Tolcapone—Pain—Vincristine—colon cancer	0.000918	0.00138	CcSEcCtD
Tolcapone—Constipation—Vincristine—colon cancer	0.000918	0.00138	CcSEcCtD
Tolcapone—Asthma—Methotrexate—colon cancer	0.000916	0.00138	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000913	0.00138	CcSEcCtD
Tolcapone—Decreased appetite—Irinotecan—colon cancer	0.000909	0.00137	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000903	0.00136	CcSEcCtD
Tolcapone—Fatigue—Irinotecan—colon cancer	0.000902	0.00136	CcSEcCtD
Tolcapone—Paraesthesia—Fluorouracil—colon cancer	0.0009	0.00136	CcSEcCtD
Tolcapone—Pain—Irinotecan—colon cancer	0.000894	0.00135	CcSEcCtD
Tolcapone—Constipation—Irinotecan—colon cancer	0.000894	0.00135	CcSEcCtD
Tolcapone—Angiopathy—Capecitabine—colon cancer	0.000894	0.00135	CcSEcCtD
Tolcapone—Dyspnoea—Fluorouracil—colon cancer	0.000893	0.00135	CcSEcCtD
Tolcapone—Somnolence—Fluorouracil—colon cancer	0.000891	0.00134	CcSEcCtD
Tolcapone—Mediastinal disorder—Capecitabine—colon cancer	0.000888	0.00134	CcSEcCtD
Tolcapone—Chills—Capecitabine—colon cancer	0.000884	0.00133	CcSEcCtD
Tolcapone—Dyspepsia—Fluorouracil—colon cancer	0.000882	0.00133	CcSEcCtD
Tolcapone—Arrhythmia—Capecitabine—colon cancer	0.00088	0.00133	CcSEcCtD
Tolcapone—Gastrointestinal pain—Vincristine—colon cancer	0.000878	0.00132	CcSEcCtD
Tolcapone—Decreased appetite—Fluorouracil—colon cancer	0.000871	0.00131	CcSEcCtD
Tolcapone—Alopecia—Capecitabine—colon cancer	0.000871	0.00131	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000865	0.0013	CcSEcCtD
Tolcapone—Mental disorder—Capecitabine—colon cancer	0.000863	0.0013	CcSEcCtD
Tolcapone—Feeling abnormal—Irinotecan—colon cancer	0.000862	0.0013	CcSEcCtD
Tolcapone—Dysuria—Methotrexate—colon cancer	0.000857	0.00129	CcSEcCtD
Tolcapone—Pain—Fluorouracil—colon cancer	0.000857	0.00129	CcSEcCtD
Tolcapone—Gastrointestinal pain—Irinotecan—colon cancer	0.000855	0.00129	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Methotrexate—colon cancer	0.000852	0.00128	CcSEcCtD
Tolcapone—Body temperature increased—Vincristine—colon cancer	0.000849	0.00128	CcSEcCtD
Tolcapone—Abdominal pain—Vincristine—colon cancer	0.000849	0.00128	CcSEcCtD
Tolcapone—Flatulence—Capecitabine—colon cancer	0.000845	0.00127	CcSEcCtD
Tolcapone—Erectile dysfunction—Methotrexate—colon cancer	0.000844	0.00127	CcSEcCtD
Tolcapone—Dysgeusia—Capecitabine—colon cancer	0.00084	0.00127	CcSEcCtD
Tolcapone—Abdominal pain—Irinotecan—colon cancer	0.000827	0.00125	CcSEcCtD
Tolcapone—Body temperature increased—Irinotecan—colon cancer	0.000827	0.00125	CcSEcCtD
Tolcapone—Feeling abnormal—Fluorouracil—colon cancer	0.000826	0.00124	CcSEcCtD
Tolcapone—Muscle spasms—Capecitabine—colon cancer	0.000825	0.00124	CcSEcCtD
Tolcapone—Pneumonia—Methotrexate—colon cancer	0.000822	0.00124	CcSEcCtD
Tolcapone—Infestation NOS—Methotrexate—colon cancer	0.000817	0.00123	CcSEcCtD
Tolcapone—Infestation—Methotrexate—colon cancer	0.000817	0.00123	CcSEcCtD
Tolcapone—Vision blurred—Capecitabine—colon cancer	0.000808	0.00122	CcSEcCtD
Tolcapone—Tremor—Capecitabine—colon cancer	0.000804	0.00121	CcSEcCtD
Tolcapone—Stomatitis—Methotrexate—colon cancer	0.000796	0.0012	CcSEcCtD
Tolcapone—Ill-defined disorder—Capecitabine—colon cancer	0.000796	0.0012	CcSEcCtD
Tolcapone—Urticaria—Fluorouracil—colon cancer	0.000796	0.0012	CcSEcCtD
Tolcapone—Anaemia—Capecitabine—colon cancer	0.000793	0.00119	CcSEcCtD
Tolcapone—Body temperature increased—Fluorouracil—colon cancer	0.000792	0.00119	CcSEcCtD
Tolcapone—Hypersensitivity—Vincristine—colon cancer	0.000791	0.00119	CcSEcCtD
Tolcapone—Sweating—Methotrexate—colon cancer	0.000783	0.00118	CcSEcCtD
Tolcapone—Haematuria—Methotrexate—colon cancer	0.000779	0.00117	CcSEcCtD
Tolcapone—Malaise—Capecitabine—colon cancer	0.000774	0.00117	CcSEcCtD
Tolcapone—Epistaxis—Methotrexate—colon cancer	0.000771	0.00116	CcSEcCtD
Tolcapone—Vertigo—Capecitabine—colon cancer	0.000771	0.00116	CcSEcCtD
Tolcapone—Hypersensitivity—Irinotecan—colon cancer	0.000771	0.00116	CcSEcCtD
Tolcapone—Asthenia—Vincristine—colon cancer	0.000771	0.00116	CcSEcCtD
Tolcapone—Syncope—Capecitabine—colon cancer	0.000769	0.00116	CcSEcCtD
Tolcapone—Palpitations—Capecitabine—colon cancer	0.000758	0.00114	CcSEcCtD
Tolcapone—Loss of consciousness—Capecitabine—colon cancer	0.000754	0.00114	CcSEcCtD
Tolcapone—Asthenia—Irinotecan—colon cancer	0.00075	0.00113	CcSEcCtD
Tolcapone—Cough—Capecitabine—colon cancer	0.000749	0.00113	CcSEcCtD
Tolcapone—Hypertension—Capecitabine—colon cancer	0.000741	0.00112	CcSEcCtD
Tolcapone—Hypersensitivity—Fluorouracil—colon cancer	0.000738	0.00111	CcSEcCtD
Tolcapone—Haemoglobin—Methotrexate—colon cancer	0.000737	0.00111	CcSEcCtD
Tolcapone—Diarrhoea—Vincristine—colon cancer	0.000735	0.00111	CcSEcCtD
Tolcapone—Haemorrhage—Methotrexate—colon cancer	0.000734	0.00111	CcSEcCtD
Tolcapone—Myalgia—Capecitabine—colon cancer	0.00073	0.0011	CcSEcCtD
Tolcapone—Arthralgia—Capecitabine—colon cancer	0.00073	0.0011	CcSEcCtD
Tolcapone—Chest pain—Capecitabine—colon cancer	0.00073	0.0011	CcSEcCtD
Tolcapone—Pharyngitis—Methotrexate—colon cancer	0.000728	0.0011	CcSEcCtD
Tolcapone—Anxiety—Capecitabine—colon cancer	0.000728	0.0011	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000725	0.00109	CcSEcCtD
Tolcapone—Urinary tract disorder—Methotrexate—colon cancer	0.000724	0.00109	CcSEcCtD
Tolcapone—Discomfort—Capecitabine—colon cancer	0.000722	0.00109	CcSEcCtD
Tolcapone—Urethral disorder—Methotrexate—colon cancer	0.000719	0.00108	CcSEcCtD
Tolcapone—Diarrhoea—Irinotecan—colon cancer	0.000716	0.00108	CcSEcCtD
Tolcapone—Dry mouth—Capecitabine—colon cancer	0.000714	0.00108	CcSEcCtD
Tolcapone—Dizziness—Vincristine—colon cancer	0.00071	0.00107	CcSEcCtD
Tolcapone—Pruritus—Fluorouracil—colon cancer	0.000709	0.00107	CcSEcCtD
Tolcapone—Confusional state—Capecitabine—colon cancer	0.000706	0.00106	CcSEcCtD
Tolcapone—Oedema—Capecitabine—colon cancer	0.0007	0.00106	CcSEcCtD
Tolcapone—Infection—Capecitabine—colon cancer	0.000695	0.00105	CcSEcCtD
Tolcapone—Erythema multiforme—Methotrexate—colon cancer	0.000694	0.00105	CcSEcCtD
Tolcapone—Dizziness—Irinotecan—colon cancer	0.000692	0.00104	CcSEcCtD
Tolcapone—Shock—Capecitabine—colon cancer	0.000689	0.00104	CcSEcCtD
Tolcapone—Nervous system disorder—Capecitabine—colon cancer	0.000687	0.00103	CcSEcCtD
Tolcapone—Diarrhoea—Fluorouracil—colon cancer	0.000685	0.00103	CcSEcCtD
Tolcapone—Thrombocytopenia—Capecitabine—colon cancer	0.000685	0.00103	CcSEcCtD
Tolcapone—Tinnitus—Methotrexate—colon cancer	0.000684	0.00103	CcSEcCtD
Tolcapone—Tachycardia—Capecitabine—colon cancer	0.000683	0.00103	CcSEcCtD
Tolcapone—Vomiting—Vincristine—colon cancer	0.000683	0.00103	CcSEcCtD
Tolcapone—Skin disorder—Capecitabine—colon cancer	0.00068	0.00102	CcSEcCtD
Tolcapone—Rash—Vincristine—colon cancer	0.000677	0.00102	CcSEcCtD
Tolcapone—Hyperhidrosis—Capecitabine—colon cancer	0.000677	0.00102	CcSEcCtD
Tolcapone—Dermatitis—Vincristine—colon cancer	0.000677	0.00102	CcSEcCtD
Tolcapone—Headache—Vincristine—colon cancer	0.000673	0.00101	CcSEcCtD
Tolcapone—Anorexia—Capecitabine—colon cancer	0.000667	0.00101	CcSEcCtD
Tolcapone—Angiopathy—Methotrexate—colon cancer	0.000666	0.001	CcSEcCtD
Tolcapone—Vomiting—Irinotecan—colon cancer	0.000665	0.001	CcSEcCtD
Tolcapone—Dizziness—Fluorouracil—colon cancer	0.000662	0.000998	CcSEcCtD
Tolcapone—Mediastinal disorder—Methotrexate—colon cancer	0.000661	0.000996	CcSEcCtD
Tolcapone—Rash—Irinotecan—colon cancer	0.00066	0.000994	CcSEcCtD
Tolcapone—Dermatitis—Irinotecan—colon cancer	0.000659	0.000993	CcSEcCtD
Tolcapone—Chills—Methotrexate—colon cancer	0.000658	0.000992	CcSEcCtD
Tolcapone—Headache—Irinotecan—colon cancer	0.000655	0.000988	CcSEcCtD
Tolcapone—Hypotension—Capecitabine—colon cancer	0.000654	0.000986	CcSEcCtD
Tolcapone—Alopecia—Methotrexate—colon cancer	0.000648	0.000977	CcSEcCtD
Tolcapone—Mental disorder—Methotrexate—colon cancer	0.000643	0.000969	CcSEcCtD
Tolcapone—Nausea—Vincristine—colon cancer	0.000638	0.000962	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000638	0.000961	CcSEcCtD
Tolcapone—Vomiting—Fluorouracil—colon cancer	0.000637	0.00096	CcSEcCtD
Tolcapone—Rash—Fluorouracil—colon cancer	0.000632	0.000952	CcSEcCtD
Tolcapone—Dermatitis—Fluorouracil—colon cancer	0.000631	0.000951	CcSEcCtD
Tolcapone—Paraesthesia—Capecitabine—colon cancer	0.000629	0.000947	CcSEcCtD
Tolcapone—Headache—Fluorouracil—colon cancer	0.000628	0.000946	CcSEcCtD
Tolcapone—Dysgeusia—Methotrexate—colon cancer	0.000625	0.000942	CcSEcCtD
Tolcapone—Dyspnoea—Capecitabine—colon cancer	0.000624	0.000941	CcSEcCtD
Tolcapone—Nausea—Irinotecan—colon cancer	0.000621	0.000936	CcSEcCtD
Tolcapone—Dyspepsia—Capecitabine—colon cancer	0.000616	0.000929	CcSEcCtD
Tolcapone—Decreased appetite—Capecitabine—colon cancer	0.000609	0.000917	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000604	0.000911	CcSEcCtD
Tolcapone—Fatigue—Capecitabine—colon cancer	0.000604	0.00091	CcSEcCtD
Tolcapone—Vision blurred—Methotrexate—colon cancer	0.000602	0.000907	CcSEcCtD
Tolcapone—Pain—Capecitabine—colon cancer	0.000599	0.000902	CcSEcCtD
Tolcapone—Constipation—Capecitabine—colon cancer	0.000599	0.000902	CcSEcCtD
Tolcapone—Nausea—Fluorouracil—colon cancer	0.000595	0.000897	CcSEcCtD
Tolcapone—Ill-defined disorder—Methotrexate—colon cancer	0.000592	0.000893	CcSEcCtD
Tolcapone—Anaemia—Methotrexate—colon cancer	0.00059	0.00089	CcSEcCtD
Tolcapone—Feeling abnormal—Capecitabine—colon cancer	0.000577	0.000869	CcSEcCtD
Tolcapone—Malaise—Methotrexate—colon cancer	0.000576	0.000868	CcSEcCtD
Tolcapone—Vertigo—Methotrexate—colon cancer	0.000574	0.000865	CcSEcCtD
Tolcapone—Gastrointestinal pain—Capecitabine—colon cancer	0.000572	0.000863	CcSEcCtD
Tolcapone—Cough—Methotrexate—colon cancer	0.000557	0.00084	CcSEcCtD
Tolcapone—Urticaria—Capecitabine—colon cancer	0.000556	0.000838	CcSEcCtD
Tolcapone—Abdominal pain—Capecitabine—colon cancer	0.000553	0.000834	CcSEcCtD
Tolcapone—Body temperature increased—Capecitabine—colon cancer	0.000553	0.000834	CcSEcCtD
Tolcapone—Myalgia—Methotrexate—colon cancer	0.000544	0.000819	CcSEcCtD
Tolcapone—Chest pain—Methotrexate—colon cancer	0.000544	0.000819	CcSEcCtD
Tolcapone—Arthralgia—Methotrexate—colon cancer	0.000544	0.000819	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00054	0.000814	CcSEcCtD
Tolcapone—Discomfort—Methotrexate—colon cancer	0.000537	0.00081	CcSEcCtD
Tolcapone—Confusional state—Methotrexate—colon cancer	0.000525	0.000792	CcSEcCtD
Tolcapone—Infection—Methotrexate—colon cancer	0.000518	0.00078	CcSEcCtD
Tolcapone—Hypersensitivity—Capecitabine—colon cancer	0.000516	0.000777	CcSEcCtD
Tolcapone—Nervous system disorder—Methotrexate—colon cancer	0.000511	0.00077	CcSEcCtD
Tolcapone—Thrombocytopenia—Methotrexate—colon cancer	0.00051	0.000769	CcSEcCtD
Tolcapone—Skin disorder—Methotrexate—colon cancer	0.000506	0.000763	CcSEcCtD
Tolcapone—Hyperhidrosis—Methotrexate—colon cancer	0.000504	0.000759	CcSEcCtD
Tolcapone—Asthenia—Capecitabine—colon cancer	0.000502	0.000757	CcSEcCtD
Tolcapone—Anorexia—Methotrexate—colon cancer	0.000497	0.000749	CcSEcCtD
Tolcapone—Pruritus—Capecitabine—colon cancer	0.000495	0.000746	CcSEcCtD
Tolcapone—Hypotension—Methotrexate—colon cancer	0.000487	0.000734	CcSEcCtD
Tolcapone—Diarrhoea—Capecitabine—colon cancer	0.000479	0.000722	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000475	0.000716	CcSEcCtD
Tolcapone—Paraesthesia—Methotrexate—colon cancer	0.000468	0.000705	CcSEcCtD
Tolcapone—Dyspnoea—Methotrexate—colon cancer	0.000465	0.0007	CcSEcCtD
Tolcapone—Somnolence—Methotrexate—colon cancer	0.000463	0.000698	CcSEcCtD
Tolcapone—Dizziness—Capecitabine—colon cancer	0.000463	0.000698	CcSEcCtD
Tolcapone—Dyspepsia—Methotrexate—colon cancer	0.000459	0.000691	CcSEcCtD
Tolcapone—Decreased appetite—Methotrexate—colon cancer	0.000453	0.000683	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Methotrexate—colon cancer	0.00045	0.000678	CcSEcCtD
Tolcapone—Fatigue—Methotrexate—colon cancer	0.000449	0.000677	CcSEcCtD
Tolcapone—Pain—Methotrexate—colon cancer	0.000446	0.000672	CcSEcCtD
Tolcapone—Vomiting—Capecitabine—colon cancer	0.000445	0.000671	CcSEcCtD
Tolcapone—Rash—Capecitabine—colon cancer	0.000441	0.000665	CcSEcCtD
Tolcapone—Dermatitis—Capecitabine—colon cancer	0.000441	0.000665	CcSEcCtD
Tolcapone—Headache—Capecitabine—colon cancer	0.000439	0.000661	CcSEcCtD
Tolcapone—Feeling abnormal—Methotrexate—colon cancer	0.000429	0.000647	CcSEcCtD
Tolcapone—Gastrointestinal pain—Methotrexate—colon cancer	0.000426	0.000642	CcSEcCtD
Tolcapone—Nausea—Capecitabine—colon cancer	0.000416	0.000627	CcSEcCtD
Tolcapone—Urticaria—Methotrexate—colon cancer	0.000414	0.000624	CcSEcCtD
Tolcapone—Abdominal pain—Methotrexate—colon cancer	0.000412	0.000621	CcSEcCtD
Tolcapone—Body temperature increased—Methotrexate—colon cancer	0.000412	0.000621	CcSEcCtD
Tolcapone—Hypersensitivity—Methotrexate—colon cancer	0.000384	0.000579	CcSEcCtD
Tolcapone—Asthenia—Methotrexate—colon cancer	0.000374	0.000564	CcSEcCtD
Tolcapone—Pruritus—Methotrexate—colon cancer	0.000369	0.000556	CcSEcCtD
Tolcapone—Diarrhoea—Methotrexate—colon cancer	0.000357	0.000537	CcSEcCtD
Tolcapone—Dizziness—Methotrexate—colon cancer	0.000345	0.000519	CcSEcCtD
Tolcapone—Vomiting—Methotrexate—colon cancer	0.000331	0.000499	CcSEcCtD
Tolcapone—Rash—Methotrexate—colon cancer	0.000329	0.000495	CcSEcCtD
Tolcapone—Dermatitis—Methotrexate—colon cancer	0.000328	0.000495	CcSEcCtD
Tolcapone—Headache—Methotrexate—colon cancer	0.000326	0.000492	CcSEcCtD
Tolcapone—Nausea—Methotrexate—colon cancer	0.00031	0.000467	CcSEcCtD
